Anti-Snoring Devices and Snoring Surgery Market to be Valued at US$ 22.92 Billion by 2032

The anti-snoring devices and snoring surgery market was valued at US$ 21.32 billion in FY 2021, and it is expected to expand by 6.0% year on year in 2022, finishing at US$ 22.92 billion. Furthermore, from 2022 to 2032, growth is predicted to accelerate at a staggering 7.5% CAGR, reaching US$ 47.23 billion.

Sedentary lifestyles, increased alcohol and smoking intake, and consumption of unhealthy and processed foods all contribute to an increase in the number of people suffering from obesity. Obesity-related disorders include stroke, type 2 diabetes, heart disease, and certain types of cancer, all of which are leading causes of unnecessary mortality. Furthermore, obesity might lead to snoring and sleep apnea.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4322

Key Market Trends:

One of the most noticeable developments in the anti-snoring device market is a growing desire for non-invasive and comfortable options like nasal strips, oral appliances, and nasal dilators. These devices relieve snoring by increasing airflow and decreasing nasal congestion, making them a handy alternative to standard therapies.

Technological advancements have also resulted in the creation of smart anti-snoring gadgets that include sensors and networking features. These devices monitor sleep patterns, detect snoring episodes, and provide real-time feedback to users, allowing for more tailored treatment and better sleep quality.

Country-wise Analysis

The Anti-Snoring market is currently dominated by North America, with the United States and Canada providing significant growth prospects. As of 2019, the US market generated $8.3 billion in sales for the North American landscape.

According to the Sleep Foundation, over 57% of men and 40% of women snored in 2019. Furthermore, the Centers for Disease Control and Prevention reported that obesity prevalence in the United States was 42.4% in 2019, up 26% from 2008.

In February 2021, the Food and Drug Administration approved the marketing of the eXciteOSA device to treat mild obstructive sleep apnea in patients aged 18 and up. Such activities increase chances for Anti-Snoring Device sales in the country. According to Fact.MR, the United States is anticipated to grow at a CAGR of 7.4% until 2032.

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.factmr.com/report/4322/anti-snoring-devices-and-snoring-surgery-market

Competitive Landscape

Prominent participants in the Anti-Snoring Devices and Snoring Surgery Industry are capitalizing on the constantly growing demand in a variety of applications. To broaden their reach, players are turning to collaborations, partnerships, and acquisitions with existing small, medium, and large-scale providers.

Some notable market developments are as follows:

Signifier, a British biotechnology start-up, said in December 2020 that it would introduce its new anti-snoring gadget in the United States. The corporation sought to raise a goal capital of $100 billion.

Fisher & Paykel Healthcare's fourth research and manufacturing center, located in New Zealand's Daniell Building, opened in July 2020. This expansion is expected to help the company continue to develop and offer premier healthcare solutions for sleep problems.

In April 2019, Zyppah gained FDA clearance to market its oral anti-snoring device in the United States. The company obtained over-the-counter device approval for marketing the gadget.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4322

Key Segments Covered in the Anti-Snoring Devices and Snoring Surgery Industry Survey

By Device :
Mandibular Advancement Anti-Snoring Devices (MAD)
Tongue Stabilizing Anti-Snoring Device (TSD)
Continuous Positive Airway Pressure (CPAP) Anti-Snoring Devices
Others (Nasal and Chin Strips, Straps, Rings, etc.)
By Surgical Procedure :
Uvulopalatopharyngoplasty (UPPP) Snoring Surgery
Tonsillectomy and Adenoidectomy Snoring Surgery
Maxillo-Mandibular and Genloglossus Advancement Surgeries
Radiofrequency Ablation (RFA) Snoring Surgery
Pillar Procedure with Palatal Implants Snoring Surgery
By Region :
North America
Europe
Latin America
Asia Pacific
Middle East & Africa

𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.